Company intelligence / Profile preview

Obvius Investment

Redwood City, California, United States

Ownership: Private
Development stage: Other

Overview

Obvius was a medical device company focused on developing innovative solutions for vascular access and clinical procedures. The company's flagship product, the C-Port Distal Access Device, was designed to simplify and improve the safety of central venous catheterization by providing a more controlled and precise entry point. By addressing common complications associated with traditional vascular access methods, Obvius aimed to enhance patient outcomes and clinical efficiency. The company was acquired by Teleflex in 2020 to integrate its distal access technology into Teleflex's broader vascular access portfolio.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Obvius Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obvius Investment.

Explore the full profile